BRPI0818723A2 - composição, alimento funcional, fórmula infantil, métodos para melhorar, promover ou manter o desenvolvimento de funções cognitivas em um bebê, o desenvolvimento de cérebro e retina em um bebê, o desenvolvimento de acuidades visuais em um bebê, a qualidade de crescimento de um bebê, o desenvolvimento do sistema nervoso central em um bebê, e maturidade intestinal em bebês, para reduzir peroxidação de lipídio em um bebê, e para aumentar absorção intestinal de ácidos graxos ômega-3 e/ou ômega-6 em bebês, e, uso de uma composição - Google Patents

composição, alimento funcional, fórmula infantil, métodos para melhorar, promover ou manter o desenvolvimento de funções cognitivas em um bebê, o desenvolvimento de cérebro e retina em um bebê, o desenvolvimento de acuidades visuais em um bebê, a qualidade de crescimento de um bebê, o desenvolvimento do sistema nervoso central em um bebê, e maturidade intestinal em bebês, para reduzir peroxidação de lipídio em um bebê, e para aumentar absorção intestinal de ácidos graxos ômega-3 e/ou ômega-6 em bebês, e, uso de uma composição

Info

Publication number: BRPI0818723A2
Authority: BR; Brazil
Prior art keywords: infant; development; infants; omega; composition
Prior art date: 2007-11-01

Application number

BRPI0818723A

Other languages

English (en)

Inventor

Katz Ariel

Pelled Dori

Bar Yosef Fabiana

Original Assignee

Enzymotec Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-01

Filing date

2008-11-02

Publication date

2017-05-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40349932&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0818723(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-11-02 Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd

2017-05-23 Publication of BRPI0818723A2 publication Critical patent/BRPI0818723A2/pt

2020-02-27 Publication of BRPI0818723B1 publication Critical patent/BRPI0818723B1/pt

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pediatric Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BRPI0818723-1A 2007-11-01 2008-11-02 Composição para nutrição infantil BRPI0818723B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US99610907P	2007-11-01	2007-11-01
US60/996,109		2007-11-01
PCT/IL2008/001437 WO2009057121A1 (en)	2007-11-01	2008-11-02	Lipid mixture for infant nutrition

Publications (2)

Publication Number	Publication Date
BRPI0818723A2 true BRPI0818723A2 (pt)	2017-05-23
BRPI0818723B1 BRPI0818723B1 (pt)	2020-02-27

Family

ID=40349932

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0818723-1A BRPI0818723B1 (pt)	2007-11-01	2008-11-02	Composição para nutrição infantil

Country Status (11)

Country	Link
US (2)	US8975299B2 (pt)
EP (1)	EP2230942B1 (pt)
KR (2)	KR101597372B1 (pt)
CN (2)	CN101909467B (pt)
AU (1)	AU2008320328B2 (pt)
BR (1)	BRPI0818723B1 (pt)
CA (1)	CA2704345C (pt)
ES (1)	ES2660416T3 (pt)
MX (1)	MX2010004820A (pt)
RU (2)	RU2488283C2 (pt)
WO (1)	WO2009057121A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101909467B (zh)	2007-11-01	2013-04-24	恩兹默泰克有限公司	用于婴儿营养的脂质混合物
SI2554056T1 (sl)	2008-09-02	2020-02-28	N.V. Nutricia	Prehranski sestavki z lipidnimi globulami velikega premera z oblogo, ki obsega fosfolipide
WO2010068086A1 (en)	2008-12-11	2010-06-17	N.V. Nutricia	Nutritional compositions with large lipid globule size
CN102665431A (zh) *	2009-11-03	2012-09-12	帝斯曼知识产权资产管理有限公司	包含细胞和具有至少20个碳原子的多不饱和脂肪酸(lc-pufa)的组合物
WO2011115476A1 (en) *	2010-03-17	2011-09-22	N.V. Nutricia	Infant nutrition for improving fatty acid composition of brain membranes later in life
EP3384902B1 (en)	2012-02-17	2020-12-30	Alcresta Therapeutics, Inc.	Methods, compositions, and devices for supplying dietary fatty acid needs
SE536599C3 (sv) *	2012-04-10	2017-01-10	Hero Ag	Näringssammansättning med lågt kalori- och lågt proteininnehåll
MY195405A (en) *	2013-03-13	2023-01-19	Abbott Lab	Method of Enhancing Bioavailability of DHA and Other Lipid-Soluble Nutrients
US20160166527A1 (en)	2013-08-01	2016-06-16	Loders Croklaan B.V.	Glyceride Composition
ES2693519T3 (es)	2013-11-01	2018-12-12	N.V. Nutricia	Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
US9216199B2 (en)	2013-12-05	2015-12-22	Buriva, LLC	Nutritional supplement containing phospholipid-DHA derived from eggs
US9610302B2 (en)	2013-12-05	2017-04-04	Buriva, LLC.	Composition containing phospholipid-DHA and B vitamins
US9549937B2 (en)	2013-12-05	2017-01-24	Burvia, LLC.	Composition containing phospholipid-DHA and folate
US9233114B2 (en)	2013-12-05	2016-01-12	Buriva, LLC	Dietary supplement containing phospholipid-DHA derived from eggs
EP3079497B1 (en) *	2013-12-12	2019-10-23	Société des Produits Nestlé S.A.	Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function
SG11201704399RA (en) *	2014-12-23	2017-07-28	Evonik Degussa Gmbh	Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
US10798962B2 (en) *	2014-12-23	2020-10-13	Evonik Operations Gmbh	Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
WO2017009711A1 (en) *	2015-07-13	2017-01-19	Enzymotec Ltd.	Phospholipid preparations for the improvement of sleep
US10258590B2 (en)	2015-10-14	2019-04-16	Alcresta Therapeutics, Inc.	Enteral feeding device and related methods of use
EP3574771B1 (en)	2015-10-15	2022-11-16	N.V. Nutricia	Infant formula with special lipid architecture for promoting healthy growth
CN105595323A (zh) *	2015-12-02	2016-05-25	北京世纪合辉医药科技股份有限公司	一种磷脂、不饱和脂肪酸复方保健品及其制备方法
MX2018006295A (es) *	2015-12-14	2018-08-16	Nestec Sa	Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
US11478011B2 (en)	2015-12-14	2022-10-25	Societe Des Produits Nestle S.A.	Nutritional compositions and infant formula for promoting de novo myealination
US10941385B2 (en) *	2016-09-23	2021-03-09	Wake Forest University	Modified microorganisms as sustainable sources of omega-3 polyunsaturated fatty acid production
ES2987545T3 (es)	2016-12-09	2024-11-15	Nutricia Nv	Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo
CN120360984A (zh)	2019-07-17	2025-07-25	贝克心脏与糖尿病研究所	用于维持或调节人体组织中醚脂质分子混合物的组合物
WO2021219634A2 (en) *	2020-04-27	2021-11-04	Société des Produits Nestlé S.A.	Method for producing milk like products
CN115825294B (zh) *	2023-02-07	2023-05-26	北京三元食品股份有限公司	一种用于评价婴幼儿沟通能力和发育状况的标志物组及应用
CN116008438B (zh) *	2023-02-07	2023-06-06	北京三元食品股份有限公司	一种用于评价婴幼儿精细动作发育状况的标志物组及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59502779D1 (de)	1994-10-05	1998-08-13	Milupa Gmbh & Co Kg	Phospholipidhaltige fettmischung mit lcp-fettsäuren
DE19644518A1 (de) *	1996-10-25	1998-04-30	Nutricia Nv	Wässrige Fettemulsion, diese enthaltende Nahrung und deren Verwendung
ID22744A (id)	1997-02-21	1999-12-09	Abbott Lab Cs	Metoda dan komposisi untuk mengurangi pengaruh dari nekrotisasi enterkolitis
US20040143013A1 (en) *	2000-02-28	2004-07-22	Bristol-Myers Squibb Company	Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
JP2004536059A (ja)	2001-05-14	2004-12-02	マーテックバイオサイエンシズボールダーコーポレーション	微生物、遺伝的に改変された植物種子および海洋生物由来のω−３および／またはω−６高度不飽和脂肪酸を含有する極性脂質の豊富な画分の生成および使用
AU2003220137A1 (en)	2002-03-19	2003-10-08	David J. Kyle	Microalgal feeds containing arachidonic acid and their production and use
US20050129738A1 (en) *	2002-06-16	2005-06-16	Lipogen Ltd.	Infant formula supplemented with phospholipids
EP1643862A1 (en)	2003-06-24	2006-04-12	University of Kansas Medical Center	Infant formula
US20050130937A1 (en)	2003-10-22	2005-06-16	Enzymotec Ltd.	Lipids containing omega-3 and omega-6 fatty acids
IL158554A0 (en) *	2003-10-22	2004-05-12	Enzymotec Ltd	Mimetic lipids as dietary supplements
US7935365B2 (en) *	2003-10-22	2011-05-03	Enzymotec, Ltd.	Glycerophospholipids for the improvement of cognitive functions
IL158552A0 (en) *	2003-10-22	2004-05-12	Enzymotec Ltd	Lipids containing omega-3 fatty acids
TWI365716B (en) *	2003-12-02	2012-06-11	Suntory Holdings Ltd	Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same
EP1634599A1 (en) *	2004-08-20	2006-03-15	N.V. Nutricia	Iimmune stimulatory infant nutrition
US20060229366A1 (en)	2005-04-07	2006-10-12	Lifschitz Carlos H	Method for preventing or treating respiratory infections in infants
AU2006327995B2 (en) *	2005-12-23	2012-09-13	N.V. Nutricia	Infant nutritional compositions for preventing obesity
WO2009047754A2 (en) *	2007-10-09	2009-04-16	Enzymotec Ltd.	Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
CN101909467B (zh)	2007-11-01	2013-04-24	恩兹默泰克有限公司	用于婴儿营养的脂质混合物

2008
- 2008-11-02 CN CN2008801241065A patent/CN101909467B/zh not_active Expired - Fee Related
- 2008-11-02 ES ES08844965.7T patent/ES2660416T3/es active Active
- 2008-11-02 CN CN2013101277089A patent/CN103202353A/zh active Pending
- 2008-11-02 MX MX2010004820A patent/MX2010004820A/es active IP Right Grant
- 2008-11-02 US US12/740,543 patent/US8975299B2/en active Active
- 2008-11-02 AU AU2008320328A patent/AU2008320328B2/en active Active
- 2008-11-02 EP EP08844965.7A patent/EP2230942B1/en not_active Revoked
- 2008-11-02 KR KR1020107011923A patent/KR101597372B1/ko active Active
- 2008-11-02 BR BRPI0818723-1A patent/BRPI0818723B1/pt not_active IP Right Cessation
- 2008-11-02 RU RU2010122055/13A patent/RU2488283C2/ru not_active Application Discontinuation
- 2008-11-02 CA CA2704345A patent/CA2704345C/en not_active Expired - Fee Related
- 2008-11-02 WO PCT/IL2008/001437 patent/WO2009057121A1/en not_active Ceased
- 2008-11-02 KR KR1020157031387A patent/KR20150126977A/ko not_active Ceased
- 2008-11-02 RU RU2013116385A patent/RU2611808C2/ru active
2015
- 2015-01-26 US US14/604,974 patent/US20150148316A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2704345A1 (en)	2009-05-07
AU2008320328A1 (en)	2009-05-07
KR20100094490A (ko)	2010-08-26
RU2611808C2 (ru)	2017-03-01
RU2013116385A (ru)	2014-10-20
MX2010004820A (es)	2010-08-10
ES2660416T3 (es)	2018-03-22
US8975299B2 (en)	2015-03-10
BRPI0818723B1 (pt)	2020-02-27
KR101597372B1 (ko)	2016-02-24
AU2008320328B2 (en)	2014-10-02
CN101909467A (zh)	2010-12-08
CN101909467B (zh)	2013-04-24
US20100298273A1 (en)	2010-11-25
EP2230942B1 (en)	2018-01-10
WO2009057121A1 (en)	2009-05-07
EP2230942A1 (en)	2010-09-29
KR20150126977A (ko)	2015-11-13
US20150148316A1 (en)	2015-05-28
CA2704345C (en)	2016-07-26
CN103202353A (zh)	2013-07-17
RU2488283C2 (ru)	2013-07-27
RU2010122055A (ru)	2011-12-10

Publication	Publication Date	Title
BRPI0818723A2 (pt)	2017-05-23	composição, alimento funcional, fórmula infantil, métodos para melhorar, promover ou manter o desenvolvimento de funções cognitivas em um bebê, o desenvolvimento de cérebro e retina em um bebê, o desenvolvimento de acuidades visuais em um bebê, a qualidade de crescimento de um bebê, o desenvolvimento do sistema nervoso central em um bebê, e maturidade intestinal em bebês, para reduzir peroxidação de lipídio em um bebê, e para aumentar absorção intestinal de ácidos graxos ômega-3 e/ou ômega-6 em bebês, e, uso de uma composição
WO2013068879A3 (en)	2013-07-11	Infant formula with high sn-2 palmitate and oligofructose
BR112012023267A2 (pt)	2017-10-03	Método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição
NZ613165A (en)	2015-02-27	Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof
EP4382108A3 (en)	2024-08-28	Synergistic production of butyrate associated with the complexity of hmos blend for use in infants or young children for health purposes
MY175195A (en)	2020-06-15	Nutritional compositions
BRPI1013013A2 (pt)	2015-09-15	"composição nutricional para suporte do desenvolvimento cerebral e função de criança"
BR112014019927B8 (pt)	2021-11-16	Fórmula nutricional, seu método de preparação, seu uso, dispositivos e composição
BRPI1011089A2 (pt)	2015-08-25	Composição nutricional para estimular o desenvolvimento e a função cerebral de crianças.
EA200970238A1 (ru)	2009-12-30	ПРИМЕНЕНИЕ МАСЕЛ С DPA(n-6) В ДЕТСКОМ ПИТАНИИ
CO6420320A2 (es)	2012-04-16	Productos que comprenden amidas de n-fenilpropenoil amino ácido y usos de los mismos
MX2013007674A (es)	2014-03-27	Productos nutricionales que incluyen monogliceridos y acidos grasos.
BRPI0820116A2 (pt)	2014-10-07	Produto alimentar incluindo um ou mais ácidos graxos de ômega-3 e um ou mais sabores de fruta
PH12013500716A1 (en)	2019-03-22	Age-tailored nutritional composition with animal fats and vegetable fats
BRPI0915337A2 (pt)	2017-06-13	usos de gordura vegetal, proteína e carboidrato e da fórmula líquida de leite para bebê, recipiente contendo uma fórmula líquida de leite para bebê, processo para preparar uma fórmula líquida de leite para bebê, fórmula líquida de leite para bebê, e, pó.
BR112015023011A2 (pt)	2017-07-18	fórmula para bebês contendo baixa caloria
WO2012004273A3 (en)	2013-03-07	Array of age-tailored nutritional formula with optimum fat content
PH12017500202A1 (en)	2017-07-10	Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses
BR112015001794A2 (pt)	2017-07-04	composição cremosa nutritiva
PH12016501111A1 (en)	2016-08-15	Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste
BR112015020568A2 (pt)	2017-07-18	composição para melhorar o desenvolvimento cognitivo, cerebral e/ou do snc do recém-nascido e método para o uso da mesma
PH12017500632B1 (en)	2020-01-29	Infant nutrition with hydrolysed protein and palmitic acid
RU2016112528A (ru)	2017-10-10	Лактоферрин, улучшение памяти и повышение скорости обучения у детей
Petrova et al.	2013	Pharyngolaryngeal reflux as one of the causes of chronic excretory otitis media
Correll et al.	2013	Selective Effect s of Individual Antipsychotic Cotreatments on Cardiometabolic and Hormonal Risk Status: Results from a Systematic Review and Meta-analysis

Legal Events

Date	Code	Title	Description
2017-06-20	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2017-08-29	B15K	Others concerning applications: alteration of classification	Ipc: A23L 33/115 (2016.01), A23L 33/12 (2016.01), A23L
2018-03-06	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-09-25	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-10-02	B07B	Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]	Free format text: ANULADA A PUBLICACAO DO CODIGO 7.4 NA RPI NO 2461 DE 06/03/2018 POR TER SIDO INDEVIDA, TENDO EM VISTA QUE A MATERIA OBJETO DO PEDIDO DE PATENTE NAO SE ESQUADRA NO ART. 229-C DA LPI
2019-09-03	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-01-07	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-02-27	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/02/2020, OBSERVADAS AS CONDICOES LEGAIS.
2022-08-23	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 14A ANUIDADE.
2022-12-13	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2694 DE 23-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.